VLA 0.00% $1.75 viralytics limited

Todays Volume . Sorry !, page-12

  1. 245 Posts.
    lightbulb Created with Sketch. 20


    Not long to wait for an update on the CANON clinical trial.

    http://eaumunich2016.uroweb.org/sci...ession/new-technologies-in-endo-urology/7558/

    Monday 14th March
    13:28 - 13:32
    Late Breaking News: Phase I/II CANON study: Novel oncolytic immunotherapy for the treatment of Non-Muscle Invasive Bladder Cancer using intravesical CAVATAK (Coxsackievirus A21)
    H. Pandha, Guildford (GB)


    .....
 
watchlist Created with Sketch. Add VLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.